Clinical Trial Update: NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the sequence of anthracycline and taxane in neoadjuvant therapy for breast cancer; results not yet reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN